These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 7912931

  • 1. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T, Gotanda K, Sasaki T, Shinbo A, Asano H, Miyazawa K, Miyasaka K.
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [Abstract] [Full Text] [Related]

  • 2. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N, Endoh M, Iijima T, Satoh K, Yanagisawa T, Yamashita S, Maruyama M, Kawada M, Morita T, Wada Y.
    Arzneimittelforschung; 1984 May; 34(3A):347-55. PubMed ID: 6331465
    [Abstract] [Full Text] [Related]

  • 3. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
    Berger C, Meyer W, Scholz H, Starbatty J.
    Arzneimittelforschung; 1985 May; 35(11):1668-73. PubMed ID: 2418846
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K, Wada Y, Taira N.
    Arzneimittelforschung; 1986 May; 36(1):35-9. PubMed ID: 2937413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M, Sugawara H, Yoshimura A, Ogura A, Yoshioka K, Sakato M, Endoh M.
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [Abstract] [Full Text] [Related]

  • 8. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M, Satoh K, Taira N.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D, von der Leyen H, Meyer W, Schmidt-Schumacher C, Scholz H.
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [Abstract] [Full Text] [Related]

  • 13. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
    Takahashi K, Tsuchida K, Aihara H.
    Arch Int Pharmacodyn Ther; 1988 Sep; 295():157-73. PubMed ID: 3245731
    [Abstract] [Full Text] [Related]

  • 14. Effects of the triazolopyrimidine trapidil on force of contraction, beating frequency and phosphodiesterase I--IV activity in guinea-pig hearts.
    Bethke T, Mehl H, Meyer W, Schmitz W, Scholz H, Thomas K, Wenzlaff H.
    Arzneimittelforschung; 1991 May; 41(5):461-8. PubMed ID: 1716891
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone.
    Armah BI, Hofferber E, Stenzel W.
    Arzneimittelforschung; 1988 Sep; 38(9):1287-92. PubMed ID: 2906245
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
    Satoh K, Kawada M, Wada Y, Taira N.
    Arzneimittelforschung; 1984 Sep; 34(5):563-8. PubMed ID: 6540573
    [Abstract] [Full Text] [Related]

  • 17. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D, Heers C, Ravens U.
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
    Hosokawa T, Mori T, Fujiki H, Kinoshita S, Takemoto K, Imaizumi T, Noda T, Ohura M, Tominaga M, Yabuuchi Y.
    Heart Vessels; 1992 Jul; 7(2):66-75. PubMed ID: 1328145
    [Abstract] [Full Text] [Related]

  • 19. Effects of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626), a new phosphodiesterase inhibitor, on the cardiovascular system of the dog.
    Furuta Y, Takahira T, Ueno M.
    Arzneimittelforschung; 1985 Jul; 35(5):827-32. PubMed ID: 4026906
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K, Taira N.
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.